30 related articles for article (PubMed ID: 31494160)
1. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer.
Sultan MH; Moni SS; Madkhali OA; Bakkari MA; Alshahrani S; Alqahtani SS; Alhakamy NA; Mohan S; Ghazwani M; Bukhary HA; Almoshari Y; Salawi A; Alshamrani M
Sci Rep; 2022 Jan; 12(1):468. PubMed ID: 35013493
[TBL] [Abstract][Full Text] [Related]
2. Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alotaibi NH; Alshehri S; Alhakamy NA; Alzarea AI; Afzal M; Elmowafy M
Int J Nanomedicine; 2020; 15():4717-4737. PubMed ID: 32636627
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Antitumor Efficacy of Chitosan-Tamarind Gum Polysaccharide Polyelectrolyte Complex Stabilized Nanoparticles of Simvastatin.
Malviya R; Raj S; Fuloria S; Subramaniyan V; Sathasivam K; Kumari U; Unnikrishnan Meenakshi D; Porwal O; Hari Kumar D; Singh A; Chakravarthi S; Kumar Fuloria N
Int J Nanomedicine; 2021; 16():2533-2553. PubMed ID: 33824590
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of magnetic hydrogels loaded with greenly synthesized iron-oxide nanoparticles conjugated with cisplatin.
Shammeri A; Abu-Huwaij R; Hamed R
Pharm Dev Technol; 2024 Apr; 29(4):383-392. PubMed ID: 38619087
[TBL] [Abstract][Full Text] [Related]
5. Preparation, Characterization, and Anticancer Activity Assessment of Chitosan/TPP Nanoparticles Loaded with
Kancha MM; Mehrabi M; Bitaraf FS; Vahedi H; Alizadeh M; Bernkop-Schnürch A
Anticancer Agents Med Chem; 2024; 24(7):533-543. PubMed ID: 38243949
[TBL] [Abstract][Full Text] [Related]
6. Crosslinked chitosan-dextran sulfate nanoparticle for improved topical ocular drug delivery.
Chaiyasan W; Srinivas SP; Tiyaboonchai W
Mol Vis; 2015; 21():1224-34. PubMed ID: 26604662
[TBL] [Abstract][Full Text] [Related]
7. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice.
Yadav M; Parle M; Sharma N; Dhingra S; Raina N; Jindal DK
Drug Deliv; 2017 Nov; 24(1):1429-1440. PubMed ID: 28942680
[TBL] [Abstract][Full Text] [Related]
8. Diosgenin Loaded Polymeric Nanoparticles with Potential Anticancer Efficacy.
Sharma N; Singhal M; Kumari RM; Gupta N; Manchanda R; Syed A; Bahkali AH; Nimesh S
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339083
[TBL] [Abstract][Full Text] [Related]
9. Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin.
Ambrus R; Csóka I; Fenyes E; Orosz L; Sarkadi ÁN; Burián K; Kókai D; Mukhtar M
J Pharm Sci; 2024 Jul; 113(7):1946-1959. PubMed ID: 38643899
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of chitosan nanoparticles for migraine therapy.
Gulati N; Nagaich U; Saraf SA
Sci Pharm; 2013; 81(3):843-54. PubMed ID: 24106677
[TBL] [Abstract][Full Text] [Related]
11. Development of kojic acid loaded collagen-chitosan nanoparticle as skin lightener product: in vitro and in vivo assessment.
Saeedi M; Morteza-Semnani K; Akbari J; Rahimnia SM; Ahmadi F; Choubdari H; Lotfi A; Hashemi SMH
J Biomater Sci Polym Ed; 2024 Jan; 35(1):63-84. PubMed ID: 37804323
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of chitosan hybridized zinc phosphate/hydroxyapatite core shell nanostructure and its potentiality as delivery system of oxaliplatin drug.
Sayed IR; Alfassam HE; El-Sayed MI; Abd El-Gaied IM; Allam AA; Abukhadra MR
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127734. PubMed ID: 37913876
[TBL] [Abstract][Full Text] [Related]
13. An Engineered Specificity of Anti-Neoplastic Agent Loaded Magnetic Nanoparticles for the Treatment of Breast Cancer.
Nair AB; Telsang M; Osmani RA
Polymers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771179
[TBL] [Abstract][Full Text] [Related]
14. Biopolymeric nanoencapsulation of model drug: Its development and characterisation.
Kumar S; Venkata N; Madhav S; Pandey S
Pak J Pharm Sci; 2024 Jan; 37(1):85-94. PubMed ID: 38741404
[TBL] [Abstract][Full Text] [Related]
15. Design of Chitosan-Coated, Quercetin-Loaded PLGA Nanoparticles for Enhanced PSMA-Specific Activity on LnCap Prostate Cancer Cells.
Essa D; Kondiah PPD; Kumar P; Choonara YE
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189819
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.
Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG
Front Digit Health; 2022; 4():799341. PubMed ID: 35252958
[TBL] [Abstract][Full Text] [Related]
17. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H
Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160
[TBL] [Abstract][Full Text] [Related]
18. Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential.
Pandey P; Dua K; Dureja H
Int J Biol Macromol; 2019 Oct; 139():1304-1316. PubMed ID: 31404602
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]